CLEARBRIDGE HEALTH LTD
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, mag… Read more
CLEARBRIDGE HEALTH LTD (5C6) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, CLEARBRIDGE HEALTH LTD (5C6) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CLEARBRIDGE HEALTH LTD - Net Assets Trend (None–None)
This chart illustrates how CLEARBRIDGE HEALTH LTD's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CLEARBRIDGE HEALTH LTD (None–None)
The table below shows the annual net assets of CLEARBRIDGE HEALTH LTD from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to CLEARBRIDGE HEALTH LTD's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
CLEARBRIDGE HEALTH LTD Competitors by Market Cap
The table below lists competitors of CLEARBRIDGE HEALTH LTD ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Williamson Magor & Company Limited
NSE:WILLAMAGOR
|
$1.11 Million |
|
RegenETP Inc.
PINK:RGTPQ
|
$1.11 Million |
|
Clean Energy Transition Inc.
V:TRAN
|
$1.11 Million |
|
Media Central Corporation Inc
PINK:FBOP
|
$1.11 Million |
|
BLAZE Minerals Ltd
AU:BLZ
|
$1.11 Million |
|
Rimoni
TA:RIMO
|
$1.11 Million |
|
Aino Health AB
ST:AINO
|
$1.11 Million |
|
Sonetel AB
ST:SONE
|
$1.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CLEARBRIDGE HEALTH LTD's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares CLEARBRIDGE HEALTH LTD's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently CLEARBRIDGE HEALTH LTD utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares CLEARBRIDGE HEALTH LTD's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CLEARBRIDGE HEALTH LTD (5C6) | €- | N/A | N/A | $1.11 Million |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.43 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $16.84 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |